243 related articles for article (PubMed ID: 25270851)
1. Protective effects of deep sea water against doxorubicin‑induced cardiotoxicity in H9c2 cardiac muscle cells.
Lee DH; Kim S; Nam KS
Int J Oncol; 2014 Dec; 45(6):2569-75. PubMed ID: 25270851
[TBL] [Abstract][Full Text] [Related]
2. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
Guo R; Lin J; Xu W; Shen N; Mo L; Zhang C; Feng J
Int J Mol Med; 2013 Mar; 31(3):644-50. PubMed ID: 23338126
[TBL] [Abstract][Full Text] [Related]
4. Naringin protects myocardial cells from doxorubicin‑induced apoptosis partially by inhibiting the p38MAPK pathway.
Jian CY; Ouyang HB; Xiang XH; Chen JL; Li YX; Zhou X; Wang JY; Yang Y; Zhong EY; Huang WH; Zhang HW
Mol Med Rep; 2017 Dec; 16(6):9457-9463. PubMed ID: 29152646
[TBL] [Abstract][Full Text] [Related]
5. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway.
Liu MH; Zhang Y; He J; Tan TP; Wu SJ; Guo DM; He H; Peng J; Tang ZH; Jiang ZS
Int J Mol Med; 2016 Jun; 37(6):1661-8. PubMed ID: 27081862
[TBL] [Abstract][Full Text] [Related]
7. Protective Effect of Two Alkaloids from
Zhou W; Ouyang J; Hu N; Li G; Wang H
Molecules; 2021 Mar; 26(7):. PubMed ID: 33808398
[TBL] [Abstract][Full Text] [Related]
8. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
[TBL] [Abstract][Full Text] [Related]
9. Curcumin potentiates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells through generation of reactive oxygen species.
Hosseinzadeh L; Behravan J; Mosaffa F; Bahrami G; Bahrami A; Karimi G
Food Chem Toxicol; 2011 May; 49(5):1102-9. PubMed ID: 21295102
[TBL] [Abstract][Full Text] [Related]
10. Brain-derived neurotrophic factor attenuates doxorubicin-induced cardiac dysfunction through activating Akt signalling in rats.
Hang P; Zhao J; Sun L; Li M; Han Y; Du Z; Li Y
J Cell Mol Med; 2017 Apr; 21(4):685-696. PubMed ID: 28098423
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC
Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473
[TBL] [Abstract][Full Text] [Related]
12. p-Coumaric acid mediated protection of H9c2 cells from Doxorubicin-induced cardiotoxicity: Involvement of augmented Nrf2 and autophagy.
Sunitha MC; Dhanyakrishnan R; PrakashKumar B; Nevin KG
Biomed Pharmacother; 2018 Jun; 102():823-832. PubMed ID: 29605770
[TBL] [Abstract][Full Text] [Related]
13. Diethyl Blechnic, a Novel Natural Product Isolated from
Yu J; Gao H; Wu C; Xu QM; Lu JJ; Chen X
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29921821
[TBL] [Abstract][Full Text] [Related]
14. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide attenuates doxorubicin‑induced cardiotoxicity by inhibiting calreticulin expression in H9c2 cells.
Liu MH; Zhang Y; Lin XL; He J; Tan TP; Wu SJ; Yu S; Chen L; Chen YD; Fu HY; Yuan C; Li J
Mol Med Rep; 2015 Oct; 12(4):5197-202. PubMed ID: 26134131
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of naringenin-7-O-glucoside against oxidative stress induced by doxorubicin in H9c2 cardiomyocytes.
Han XZ; Gao S; Cheng YN; Sun YZ; Liu W; Tang LL; Ren DM
Biosci Trends; 2012 Feb; 6(1):19-25. PubMed ID: 22426099
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.
Spallarossa P; Garibaldi S; Altieri P; Fabbi P; Manca V; Nasti S; Rossettin P; Ghigliotti G; Ballestrero A; Patrone F; Barsotti A; Brunelli C
J Mol Cell Cardiol; 2004 Oct; 37(4):837-46. PubMed ID: 15380674
[TBL] [Abstract][Full Text] [Related]
18. Targeted Inhibition of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Sensitizes Pancreatic Cancer Cells to Doxorubicin without Exacerbating Cardiac Toxicity.
Durrant DE; Das A; Dyer S; Tavallai S; Dent P; Kukreja RC
Mol Pharmacol; 2015 Sep; 88(3):512-23. PubMed ID: 26101222
[TBL] [Abstract][Full Text] [Related]
19. Influence of PARP-1 inhibition in the cardiotoxicity of the topoisomerase 2 inhibitors doxorubicin and mitoxantrone.
Damiani RM; Moura DJ; Viau CM; Brito V; Morás AM; Henriques JAP; Saffi J
Toxicol In Vitro; 2018 Oct; 52():203-213. PubMed ID: 29913208
[TBL] [Abstract][Full Text] [Related]
20. Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity.
Fan GC; Zhou X; Wang X; Song G; Qian J; Nicolaou P; Chen G; Ren X; Kranias EG
Circ Res; 2008 Nov; 103(11):1270-9. PubMed ID: 18948619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
